Skip to main content

Highlight Therapeutics

Paterna, Spain

Highlight Therapeutics is a clinical-stage biopharmaceutical company.

$17.8M raised
Sep 2025
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Highlight Therapeutics

How much funding has Highlight Therapeutics raised?
Highlight Therapeutics has raised $17.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2025.
Who are Highlight Therapeutics's investors?
Highlight Therapeutics's investors include Buenavista Equity Partners, Columbus Venture Partners, Centre for the Development of Industrial Technology (CDTI), Advent Life Sciences, Realiza Business Angels.
Where is Highlight Therapeutics headquartered?
Highlight Therapeutics is headquartered in Paterna, Spain.
What does Highlight Therapeutics do?
Highlight Therapeutics is a clinical-stage biopharmaceutical company.
What stage is Highlight Therapeutics at?
Highlight Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Highlight Therapeutics — Funding & Investors." VCBacked, September 16, 2025, https://www.vcbacked.co/company/highlight-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2025). Highlight Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/highlight-therapeutics
Wikipedia (cite web)
{{cite web |title=Highlight Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/highlight-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .